# Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/quantity-and-economic-value-of-unused-oral-anti-cancer-and-biological-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Charlotte L. Bekker,Eward J Melis,Toine C. G. Egberts,Marcel L. Bouvy,Helga Gardarsdóttir,Bart J. F. van den Bemt |
| Citations | 36 |
| DOI | 10.1016/j.sapharm.2018.03.064 |
| Fields | Economics, Econometrics and Finance,Health Professions |
| Open Access | true |
| OA Status | green |
| OA URL | https://cris.maastrichtuniversity.nl/en/publications/c5e41e91-72b6-4667-ac19-a1e262bf08cc |
| OpenAlex ID | https://openalex.org/W2789916977 |
| PMID | 29610051 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Charlotte L. Bekker](https://scholariq.org/researchers/charlotte-l-bekker/)

## Paper primary topic

- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

## Paper topics

- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Healthcare cost, quality, practices](https://scholariq.org/topics/healthcare-cost-quality-practices/)
- [Safe Handling of Antineoplastic Drugs](https://scholariq.org/topics/safe-handling-of-antineoplastic-drugs/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
